{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:47:07Z","timestamp":1791654427477,"version":"4.3.4"},"reference-count":161,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Colorectal cancer (CRC) is the second leading cause of cancer-related deaths globally and the thi<jats:sup>rd<\/jats:sup> most commonly diagnosed malignancy, posing a major threat to public health. Clinical manifestations such as altered bowel habits (e.g., constipation, diarrhea, or pencil-thin stools), rectal bleeding, and abdominal pain or bloating may indicate CRC. A hallmark of CRC is metabolic reprogramming, which enables tumor cells to meet the bioenergetic and biosynthetic demands of rapid proliferation and survival. This reprogramming encompasses dysregulated glycolysis, amino acid metabolism, and lipid metabolism, collectively driving tumor growth, invasion, angiogenesis, and therapeutic resistance. Targeting metabolic reprogramming has emerged as a promising strategy in CRC therapy. Inhibitors of key metabolic enzymes and signaling pathways involved in glycolysis have demonstrated efficacy in preclinical and early clinical studies. Additionally, Traditional Chinese Medicine (TCM) has attracted increasing interest for its potential to modulate tumor metabolism. This review examines current evidence on marketed drugs, TCM, and the underlying metabolic mechanisms implicated in CRC treatment. While TCM shows promise as a complementary therapeutic approach, further research is essential to validate its clinical utility and mechanistic underpinnings.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1630279","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T05:25:17Z","timestamp":1752557117000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical application prospects of traditional Chinese medicine as adjuvant therapy for metabolic reprogramming in colorectal cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Liu","family":"Zhexian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Xingqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xinxin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Siping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yanxi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000133","article-title":"Increasing trend in young-onset colorectal cancer in asia: more cancers in men and more rectal cancers","volume":"114","author":"Sung","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-309086","article-title":"Colorectal cancer screening: a global overview of existing programmes","volume":"64","author":"Schreuders","year":"2015","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21772","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102156","article-title":"Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance","volume":"50","author":"Qin","year":"2024","journal-title":"Transl Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12012-024-09937-3","article-title":"Isoprenaline inhibits histone demethylase LSD1 to induce cardiac hypertrophy","volume":"25","author":"Wu","year":"2025","journal-title":"Cardiovasc Toxicol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2020.5771","article-title":"lncRNA HOTAIR promotes DNA repair and radioresistance of breast cancer via EZH2","author":"Qian","year":"2020","journal-title":"DNA Cell Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.1133427","article-title":"The consensus coding sequences of human breast and colorectal cancers","volume":"314","author":"Sjoblom","year":"2006","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1710366114","article-title":"Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC","volume":"114","author":"Satoh","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13027-022-00470-y","article-title":"Construction and validation of prognostic signature for hepatocellular carcinoma basing on hepatitis B virus related specific genes","volume":"17","author":"Wang","year":"2022","journal-title":"Infect Agent Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15022157","article-title":"shRNA-mediated XRCC2 gene knockdown efficiently sensitizes colon tumor cells to X-ray irradiation in vitro and in vivo","volume":"15","author":"Wang","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","article-title":"Metabolic reprogramming: the emerging concept and associated therapeutic strategies","volume":"34","author":"Yoshida","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123974","article-title":"Melatonin sensitizes human colorectal cancer cells to gamma-ray ionizing radiation in vitro and in vivo","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7915.2010.00221.x","article-title":"Natural products for cancer chemotherapy","volume":"4","author":"Demain","year":"2011","journal-title":"Microb Biotechnol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105728","article-title":"Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy","volume":"170","author":"Wang","year":"2021","journal-title":"Pharmacol Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s00432-024-05982-1","article-title":"Epigenetic modulation of autophagy pathway by small molecules in colorectal cancer: a systematic review","volume":"150","author":"Zamani","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305302","article-title":"PTEN antagonises Tcl1\/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis","volume":"63","author":"Hong","year":"2014","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-3-030-12734-3_6","article-title":"Hypoxia and metabolism in metastasis","volume":"1136","author":"Zhang","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122755","article-title":"Metabolic pathways of the warburg effect in health and disease: perspectives of choice, chain or chance","volume":"18","author":"Burns","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13732","article-title":"c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-1188","article-title":"Glycolysis inhibition sensitizes non-small cell lung cancer with T790M mutation to irreversible EGFR inhibitors via translational suppression of Mcl-1 by AMPK activation","volume":"12","author":"Kim","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1242\/jeb.00241","article-title":"Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function","volume":"206","author":"Wilson","year":"2003","journal-title":"J Exp Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-008-0688-8","article-title":"Non-invasive MRI tumor imaging and synergistic anticancer effect of HSP90 inhibitor and glycolysis inhibitor in RIP1-Tag2 transgenic pancreatic tumor model","volume":"62","author":"Cao","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.08.012","article-title":"Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design","volume":"20","author":"Berruti","year":"2002","journal-title":"J Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S135849","article-title":"Co-delivery nanocarriers targeting folate receptor and encapsulating 2-deoxyglucose and alpha-tocopheryl succinate enhance anti-tumor effect in vivo","volume":"12","author":"Lei","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.521","article-title":"Metformin prevents DMH-induced colorectal cancer in diabetic rats by reversing the warburg effect","volume":"4","author":"Jia","year":"2015","journal-title":"Cancer Med"},{"key":"B29","article-title":"Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt\/mTOR signaling","volume":"29","author":"Johnson","year":"2009","journal-title":"Anticancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.53388\/PMR20230006","article-title":"Effects of curcumin on uterine leiomyoma in a rat model by inhibiting \u03b2-catenin\/Wnt signaling pathway","volume":"5","author":"Li","year":"2023","journal-title":"Precis Med Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20102454","article-title":"Mechanism of apoptosis induced by curcumin in colorectal cancer","volume":"20","author":"Ismail","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3892\/or.2015.3727","article-title":"Epigallocatechin gallate inhibits human tongue carcinoma cells via HK2\u2212mediated glycolysis","volume":"33","author":"Gao","year":"2015","journal-title":"Oncol Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41408-021-00514-3","article-title":"Acute promyelocytic leukemia current treatment algorithms","volume":"11","author":"Yilmaz","year":"2021","journal-title":"Blood Cancer J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-160143","article-title":"PFKFB3 was overexpressed in gastric cancer patients and promoted the proliferation and migration of gastric cancer cells","volume":"18","author":"Han","year":"2017","journal-title":"Cancer biomark"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-24-0077","article-title":"Tumor Vessel Normalization via PFKFB3 Inhibition Alleviates Hypoxia and Increases Tumor Necrosis in Rectal Cancer upon Radiotherapy","volume":"4","author":"Edelmann","year":"2024","journal-title":"Cancer Res Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2079182","article-title":"Glucose metabolism inhibitor PFK-015 combined with immune checkpoint inhibitor is an effective treatment regimen in cancer","volume":"11","author":"Zheng","year":"2022","journal-title":"Oncoimmunology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1308749","article-title":"Development and evaluation of oleanolic acid dosage forms and its derivatives","volume":"2020","author":"Feng","year":"2020","journal-title":"BioMed Res Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201905578","article-title":"Discovery of a potent GLUT inhibitor from a library of rapafucins by using 3D microarrays","volume":"58","author":"Guo","year":"2019","journal-title":"Angew Chem Int Ed Engl"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2014.15.17.7037","article-title":"Overcoming 5-Fu resistance of colon cells through inhibition of Glut1 by the specific inhibitor WZB117","volume":"15","author":"Liu","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1038\/s41467-020-18020-8","article-title":"GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Nat Commun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010033","article-title":"Ovarian cancer relies on glucose transporter 1 to fuel glycolysis and growth: anti-tumor activity of BAY-876","volume":"11","author":"Ma","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00833","article-title":"Targeting T cell activation and lupus autoimmune phenotypes by inhibiting glucose transporters","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188457","article-title":"Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer","volume":"1874","author":"Tilekar","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2010.12.015","article-title":"A pairwise chemical genetic screen identifies new inhibitors of glucose transport","volume":"18","author":"Ulanovskaya","year":"2011","journal-title":"Chem Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.6b02861","article-title":"Apple Polyphenol Phloretin Inhibits Colorectal Cancer Cell Growth via Inhibition of the Type 2 Glucose Transporter and Activation of p53-Mediated Signaling","volume":"64","author":"Lin","year":"2016","journal-title":"J Agric Food Chem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061305","article-title":"The therapeutic potential of apigenin","volume":"20","author":"Salehi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17303","article-title":"Effect of Glut-1 and HIF-1alpha double knockout by CRISPR\/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K\/Akt\/mTOR pathway","volume":"26","author":"Bao","year":"2022","journal-title":"J Cell Mol Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.4233","article-title":"Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1","volume":"12","author":"Fang","year":"2015","journal-title":"Mol Med Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2020.1772492","article-title":"The effect of trehalose on intracellular and extracellular nucleotide metabolism. A pilot study","volume":"39","author":"Opielka","year":"2020","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"B51","doi-asserted-by":"publisher","first-page":"fs2","DOI":"10.1126\/scisignal.aaf1937","article-title":"Mystery solved: Trehalose kickstarts autophagy by blocking glucose transport","volume":"9","author":"Mardones","year":"2016","journal-title":"Sci Signal"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22111942","article-title":"Silybin, a major bioactive component of milk thistle (Silybum marianum L. Gaernt.)-chemistry, bioavailability, and metabolism","volume":"22","author":"Bijak","year":"2017","journal-title":"Molecules"},{"key":"B53","doi-asserted-by":"publisher","first-page":"697","DOI":"10.4161\/auto.23960","article-title":"Energy deprivation by silibinin in colorectal cancer cells: a double-edged sword targeting both apoptotic and autophagic machineries","volume":"9","author":"Raina","year":"2013","journal-title":"Autophagy"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-010-9238-z","article-title":"Inhibition of cancer cell invasion and metastasis by genistein","volume":"29","author":"Pavese","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01336","article-title":"Molecular mechanisms of action of genistein in cancer: recent advances","volume":"10","author":"Tuli","year":"2019","journal-title":"Front Pharmacol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)47947-1","article-title":"The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters","volume":"262","author":"Noguchi","year":"1987","journal-title":"J Biol Chem"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26641","article-title":"A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin","volume":"10","author":"Geagea","year":"2019","journal-title":"Oncotarget"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8502","article-title":"Research progress on the anticancer effects of vitamin K2","volume":"15","author":"Xv","year":"2018","journal-title":"Oncol Lett"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1039\/d1md00045d","article-title":"Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents","volume":"12","author":"Rathod","year":"2021","journal-title":"Rsc Med Chem"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2019.08.007","article-title":"Pyruvate kinase M2: A simple molecule with complex functions","volume":"143","author":"Alquraishi","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J Clin Invest"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29092110","article-title":"Metabolic rewiring in cancer: small molecule inhibitors in colorectal cancer therapy","volume":"29","author":"Masci","year":"2024","journal-title":"Molecules"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1399508005","DOI":"10.1177\/10732748211041243","article-title":"Contemporary perspectives on the warburg effect inhibition in cancer therapy","volume":"28","author":"Kozal","year":"2021","journal-title":"Cancer Control"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.752118","article-title":"Galloflavin relieves the Malignant behavior of colorectal cancer cells in the inflammatory tumor microenvironment","volume":"12","author":"Guo","year":"2021","journal-title":"Front Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41419-025-07334-4","article-title":"DNA replication stress underpins the vulnerability to oxidative phosphorylation inhibition in colorectal cancer","volume":"16","author":"Zhao","year":"2025","journal-title":"Cell Death Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40880-019-0412-6","article-title":"Targeting mitochondria as an anticancer strategy","volume":"39","author":"Dong","year":"2019","journal-title":"Cancer Commun (Lond)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2642693","DOI":"10.1177\/17588359231197957","article-title":"Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I\/Ib clinical trial","volume":"15","author":"Bielcikova","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1089\/ars.2016.6677","article-title":"Selective disruption of respiratory supercomplexes as a new strategy to suppress her2(high) breast cancer","volume":"26","author":"Rohlenova","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"B70","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2019.04.021","article-title":"LYRM2 directly regulates complex I activity to support tumor growth in colorectal cancer by oxidative phosphorylation","volume":"455","author":"Huang","year":"2019","journal-title":"Cancer Lett"},{"key":"B71","first-page":"689","article-title":"Anti-cancer analogues ME-143 and ME-344 exert toxicity by directly inhibiting mitochondrial NADH: ubiquinone oxidoreductase (Complex I)","volume":"5","author":"Lim","year":"2015","journal-title":"Am J Cancer Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.7150\/thno.107812","article-title":"Mitochondria-targeting natural product rhein conjugated with dichloroacetate as the dual inhibitor of glycolysis and oxidative phosphorylation to off energize cancer cells and induce ROS storm","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.01.002","article-title":"Frondoside A enhances the antiproliferative effects of gemcitabine in pancreatic cancer","volume":"50","author":"Al","year":"2014","journal-title":"Eur J Cancer"},{"key":"B74","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13045-022-01358-5","article-title":"Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications","volume":"15","author":"Zhong","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.4.3.449","article-title":"Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma","volume":"4","author":"Geschwind","year":"2004","journal-title":"Expert Rev Anticancer Ther"},{"key":"B76","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.molonc.2008.01.003","article-title":"3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs","volume":"2","author":"Ihrlund","year":"2008","journal-title":"Mol Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204953","article-title":"Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437","volume":"20","author":"Belzacq","year":"2001","journal-title":"Oncogene"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2016.08.001","article-title":"Mechanism of antineoplastic activity of lonidamine","volume":"1866","author":"Nath","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1521316112","article-title":"Systematic identification of arsenic-binding proteins reveals that hexokinase-2 is inhibited by arsenic","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1097\/01.mco.0000241661.15514.fb","article-title":"6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase and tumor cell glycolysis","volume":"9","author":"Chesney","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0097","article-title":"Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer","volume":"12","author":"Clem","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032606","article-title":"Modulating glycolysis to improve cancer therapy","volume":"24","author":"Chelakkot","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.143956","article-title":"Oleanolic acid reduces aerobic glycolysis-associated proliferation by inhibiting yes-associated protein in gastric cancer cells","volume":"712","author":"Li","year":"2019","journal-title":"Gene"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2012.07.001","article-title":"The SLC2 (GLUT) family of membrane transporters","volume":"34","author":"Mueckler","year":"2013","journal-title":"Mol Aspects Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00712.2009","article-title":"Glucose transporters in the 21st century","volume":"298","author":"Thorens","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-022-00229-6","article-title":"GLUT1 production in cancer cells: a tragedy of the commons","volume":"8","author":"Bukkuri","year":"2022","journal-title":"NPJ Syst Biol Appl"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120822","article-title":"A hypoxia responsive nanoassembly for tumor specific oxygenation and enhanced sonodynamic therapy","volume":"275","author":"Yang","year":"2021","journal-title":"Biomaterials"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.166629","article-title":"Pyruvate kinase M2 at a glance","volume":"128","author":"Yang","year":"2015","journal-title":"J Cell Sci"},{"key":"B90","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s13046-019-1495-2","article-title":"Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects","volume":"38","author":"Kamarudin","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.03.013","article-title":"Vitamin K: Redox-modulation, prevention of mitochondrial dysfunction and anticancer effect","volume":"16","author":"Ivanova","year":"2018","journal-title":"Redox Biol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2011.10.039","article-title":"Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2","volume":"316","author":"Chen","year":"2012","journal-title":"Cancer Lett"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1552486","article-title":"Inhibition of colorectal cancer cell growth by downregulation of M2-PK and reduction of aerobic glycolysis by clove active ingredients","volume":"16","author":"Liu","year":"2025","journal-title":"Front Pharmacol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1021\/jm101007q","article-title":"Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells","volume":"54","author":"Granchi","year":"2011","journal-title":"J Med Chem"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150721","article-title":"Structural basis of lactate dehydrogenase A-gossypol complex","volume":"733","author":"Ha","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12080","article-title":"Targeting lactate dehydrogenase A (LDHA) exerts antileukemic effects on T-cell acute lymphoblastic leukemia","volume":"40","author":"Yu","year":"2020","journal-title":"Cancer Commun (Lond)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01013","article-title":"Why all the fuss about oxidative phosphorylation (OXPHOS)","volume":"63","author":"Xu","year":"2020","journal-title":"J Med Chem"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174279","article-title":"Ginsenoside compound K induces ros-mediated apoptosis and autophagic inhibition in human neuroblastoma cells in vitro and in vivo","volume":"20","author":"Oh","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165845","article-title":"Lipid metabolism and cancer immunotherapy: immunosuppressive myeloid cells at the crossroad","volume":"21","author":"Bleve","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020301","article-title":"Lipid metabolism as a targetable metabolic vulnerability in colorectal cancer","volume":"13","author":"Zaytseva","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14487","article-title":"Inhibitors of fatty acid synthesis and oxidation as potential anticancer agents in colorectal cancer treatment","volume":"40","author":"Mozolewska","year":"2020","journal-title":"Anticancer Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25173935","article-title":"Fatty acid synthase: an emerging target in cancer","volume":"25","author":"Fhu","year":"2020","journal-title":"Molecules"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0976","article-title":"C75 alters central and peripheral gene expression to reduce food intake and increase energy expenditure","volume":"146","author":"Tu","year":"2005","journal-title":"Endocrinology"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.10.6.12727","article-title":"High levels of fatty acid synthase expression in esophageal cancers represent a potential target for therapy","volume":"10","author":"Orita","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2011.02.016","article-title":"Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal","volume":"65","author":"Chuang","year":"2011","journal-title":"BioMed Pharmacother"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100797","article-title":"First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors","volume":"34","author":"Falchook","year":"2021","journal-title":"Eclinicalmedicine"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00248.2006","article-title":"Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin","volume":"292","author":"Lim","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0304-3835(00)00511-5","article-title":"Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells","volume":"158","author":"Schneider","year":"2000","journal-title":"Cancer Lett"},{"key":"B110","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s13046-019-1391-9","article-title":"ACLY facilitates colon cancer cell metastasis by CTNNB1","volume":"38","author":"Wen","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B111","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41419-021-03833-2","article-title":"IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R","volume":"12","author":"Qiao","year":"2021","journal-title":"Cell Death Dis"},{"key":"B112","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12935-015-0241-x","article-title":"Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy","volume":"15","author":"Ramasamy","year":"2015","journal-title":"Cancer Cell Int"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100933","article-title":"Lipid metabolism in colon cancer: Role of Liver X Receptor (LXR) and Stearoyl-CoA Desaturase 1 (SCD1)","volume":"78","author":"Piccinin","year":"2021","journal-title":"Mol Aspects Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejphar.2017.03.064","article-title":"In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor","volume":"807","author":"Nishizawa","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.132","article-title":"Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer","volume":"7","author":"Qu","year":"2016","journal-title":"Cell Death Dis"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0036","article-title":"Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies","volume":"3","author":"Hossain","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23525","article-title":"Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir","volume":"123","author":"Hernlund","year":"2008","journal-title":"Int J Cancer"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28083624","article-title":"Perhexiline: old drug, new tricks? A summary of its anti-cancer effects","volume":"28","author":"Dhakal","year":"2023","journal-title":"Molecules"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.09.009","article-title":"Reduction of squalene epoxidase by cholesterol accumulation accelerates colorectal cancer progression and metastasis","volume":"160","author":"Jun","year":"2021","journal-title":"Gastroenterology"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2011.237495","article-title":"Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell \u2018stemness\u2019 via the bone morphogenetic protein pathway","volume":"60","author":"Kodach","year":"2011","journal-title":"Gut"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S199369","article-title":"Fatty acid synthase enhances colorectal cancer cell proliferation and metastasis via regulating AMPK\/mTOR pathway","volume":"12","author":"Lu","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v6.i2.295","article-title":"Inhibitor of fatty acid synthase induced apoptosis in human colonic cancer cells","volume":"6","author":"Huang","year":"2000","journal-title":"World J Gastroenterol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00432-015-2000-8","article-title":"Loss of fatty acid synthase suppresses the Malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway","volume":"142","author":"Chang","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2007.19.2.115","article-title":"Adjuvant treatment of colon cancer: past, present and future","volume":"19","author":"Wils","year":"2007","journal-title":"J Chemother"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-238","article-title":"Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R\/Wnt and activation of p53 signaling pathways","volume":"10","author":"Vanamala","year":"2010","journal-title":"BMC Cancer"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-016-0611-4","article-title":"Bempedoic acid (ETC-1002): an investigational inhibitor of ATP citrate lyase","volume":"18","author":"Bilen","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26237368","article-title":"Berberine as a potential anticancer agent: A comprehensive review","volume":"26","author":"Rauf","year":"2021","journal-title":"Molecules"},{"key":"B128","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13046-018-0711-9","article-title":"Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN","volume":"37","author":"Ran","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23833","article-title":"Betulinic acid arrests cell cycle at G2\/M phase by up-regulating metallothionein 1G inhibiting proliferation of colon cancer cells","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.2174\/1574888x11666151203223512","article-title":"Betulinic acid kills colon cancer stem cells","volume":"11","author":"Potze","year":"2016","journal-title":"Curr Stem Cell Res Ther"},{"key":"B131","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.canlet.2019.12.036","article-title":"Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers","volume":"473","author":"Wang","year":"2020","journal-title":"Cancer Lett"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043792","article-title":"Statins and the risk of colorectal cancer","volume":"352","author":"Poynter","year":"2005","journal-title":"N Engl J Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70127","article-title":"Colorectal cancer: pathogenesis and targeted therapy","volume":"6","author":"Li","year":"2025","journal-title":"Medcomm (2020)"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-020-00783-9","article-title":"Hesperetin inhibits foam cell formation and promotes cholesterol efflux in THP-1-derived macrophages by activating LXRalpha signal in an AMPK-dependent manner","volume":"77","author":"Chen","year":"2021","journal-title":"J Physiol Biochem"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16844","article-title":"Synthetic lethality of glutaminolysis inhibition, autophagy inactivation and asparagine depletion in colon cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"B136","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12964-024-02018-6","article-title":"Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets","volume":"23","author":"Nan","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B137","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp Mol Med"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2334","article-title":"SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival","volume":"19","author":"Hassanein","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B140","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41416-019-0637-9","article-title":"ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma","volume":"122","author":"Zhang","year":"2020","journal-title":"Br J Cancer"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.108964","article-title":"GLS1 depletion inhibited colorectal cancer proliferation and migration via redox\/Nrf2\/autophagy-dependent pathway","volume":"708","author":"Liu","year":"2021","journal-title":"Arch Biochem Biophys"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175031","article-title":"Neutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer","volume":"134","author":"Li","year":"2024","journal-title":"J Clin Invest"},{"key":"B143","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4062\/biomolther.2017.178","article-title":"Targeting glutamine metabolism for cancer treatment","volume":"26","author":"Choi","year":"2018","journal-title":"Biomol Ther (Seoul)"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081632","article-title":"Clinical role of ASCT2 (SLC1A5) in KRAS-mutated colorectal cancer","volume":"18","author":"Toda","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103875","article-title":"Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitors","volume":"100","author":"Liu","year":"2020","journal-title":"Bioorg Chem"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.19540\/j.cnki.cjcmm.20240812.501","article-title":"Evidence map for randomized controlled trials of traditional Chinese medicine in prevention and treatment of colorectal cancer","volume":"49","author":"Zhang","year":"2024","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-14-362","article-title":"The quality of reports of randomized clinical trials on traditional Chinese medicine treatments: a systematic review of articles indexed in the China National Knowledge Infrastructure database from 2005 to 2012","volume":"14","author":"Li","year":"2014","journal-title":"BMC Complement Altern Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3892\/br.2018.1051","article-title":"Computer-aided design of temozolomide derivatives based on alkylglycerone phosphate synthase structure with isothiocyanate and their pharmacokinetic\/toxicity prediction and anti-tumor activity","volume":"8","author":"Yang","year":"2018","journal-title":"vitro. BioMed Rep"},{"key":"B149","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3892\/ijmm.2013.1255","article-title":"Effect of radiation on the Notch signaling pathway in osteoblasts","volume":"31","author":"Yang","year":"2013","journal-title":"Int J Mol Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8356","article-title":"Effect of alkylglycerone phosphate synthase on the expression profile of circRNAs in the human thyroid cancer cell line FRO","volume":"15","author":"Hou","year":"2018","journal-title":"Oncol Lett"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02752","article-title":"First-in-human phase I\/IB dose-finding study of adagrasib (MRTX849) in patients with advanced KRAS(G12C) solid tumors (KRYSTAL-1)","volume":"40","author":"Ou","year":"2022","journal-title":"J Clin Oncol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.112955","article-title":"Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial","volume":"190","author":"Ballhausen","year":"2023","journal-title":"Eur J Cancer"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00479-X","article-title":"Targeting the EGFR signalling pathway in metastatic colorectal cancer","volume":"9","author":"Napolitano","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13045-022-01294-4","article-title":"Exploring immunotherapy in colorectal cancer","volume":"15","author":"Weng","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","article-title":"Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-015-3858-x","article-title":"Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K","volume":"42","author":"Courtnay","year":"2015","journal-title":"Mol Biol Rep"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1563303","article-title":"Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives","volume":"16","author":"Gu","year":"2025","journal-title":"Front Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-021-00776-4","article-title":"Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01536","article-title":"Is lactate an oncometabolite? Evidence supporting a role for lactate in the regulation of transcriptional activity of cancer-related genes in MCF7 breast cancer cells","volume":"9","author":"San-Millan","year":"2019","journal-title":"Front Oncol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12032-025-02822-1","article-title":"Immune checkpoint inhibitors in cancer therapy: what lies beyond monoclonal antibodies","volume":"42","author":"Zamani","year":"2025","journal-title":"Med Oncol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1088184994","DOI":"10.1177\/17562848211002018","article-title":"Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer","volume":"14","author":"Manz","year":"2021","journal-title":"Therap Adv Gastroenterol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1630279\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T05:25:19Z","timestamp":1752557119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1630279\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":161,"alternative-id":["10.3389\/fimmu.2025.1630279"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1630279","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"article-number":"1630279"}}